Biography

Dr. Lewis has more than 20 years of experience in the pharmaceutical industry developing/validating/transferring analytical methods for release and stability testing of both small molecule drugs and biologics from early phase development through commercial. She is experienced working in a CRO/CDMO fast-paced environment managing multiple projects and delivering on aggressive timelines for customers. She currently serves as the Associate Director Analytical Development/QC at the University of Rhode Island’s College of Pharmacy’s Pharmaceutical Development Institute.

Prior to her current role, Dr. Lewis held the role of Group Leader at Catalent Pharma Solutions. In this role, she led a team of scientists providing analytical support for formulation development and release/stability testing of early phase clinical supplies. In addition, Dr. Lewis was the Senior Associate Director Analytical Sciences at FreeThink Technologies which specialized in accelerated stability studies for formulation development and shelf-life determination of drug products. She was responsible for aspects of laboratory management, direct client-sponsored project work, and helping to develop the company’s R&D strategy. Dr. Lewis also held various positions at Pfizer Pharmaceuticals working in a global analytical resources group that supported both QC and R&D. 

Dr. Lewis received her B.A. degree in chemistry from Berea College and her Ph.D. in bioanalytical chemistry from the University of Kentucky.